In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Defendant: ScieGen Pharmaceuticals, Inc.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court: Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Mylan Inc., Micro Labs Limited, Micro Labs USA, Inc., Bayer Intellectual Property GMBH, USV Private Limited, Apotex Inc., Apotex Corp., Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Teva Pharmaceutical Industries Ltd, Indoco Remedies Limited, FPP Holding Company LLC, Biocon Pharma Limited and Biocon Limited
Counter Defendant: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Case Number: 1:2021md03017
Filed: December 10, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on July 27, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 27, 2023 Filing 169 STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/27/2023 (nms).
July 27, 2023 Opinion or Order SO ORDERED Granting (D.I. 169 in 21md-3017-RGA; D.I. 10 in 23-cv-690-RGA) STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023. Signed by Judge Richard G. Andrews on 7/27/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00690-RGA(nms)
July 21, 2023 Filing 168 ANSWER to #165 Answer to Complaint, Counterclaim by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
June 30, 2023 Filing 167 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp.. (Hitch, Cortlan)
June 30, 2023 Filing 166 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (Hitch, Cortlan)
June 30, 2023 Filing 165 ANSWER to Complaint and Counterclaims against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Apotex Inc., Apotex Corp..(Hitch, Cortlan) Modified on 6/30/2023 (nms).
June 22, 2023 Filing 164 REDACTED VERSION of #157 Letter, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/22/2023 (nms).
June 21, 2023 Opinion or Order Filing 163 SO ORDERED Granting (D.I. 161 in 21-md-3017-RGA; D.I. 22 in 22-cv-1492-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
June 21, 2023 Filing 162 MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
June 21, 2023 Opinion or Order SO ORDERED, re (D.I. 10 in 23-cv-327-RGA; D.I. 162 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00327-RGA(nms)
June 20, 2023 Filing 161 STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
June 20, 2023 Opinion or Order Filing 160 SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms)
June 20, 2023 Opinion or Order Filing 159 SO ORDERED Granting (D.I. 154 in 21-md-3017-RGA; D.I. 17 in 22-cv-1596-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms)
June 16, 2023 Opinion or Order Filing 158 ORAL ORDER: The request to file another status report by 6/22/2023 (D.I. 20 in 22-cv-1492-RGA; D.I. 157 in 21-md-3017-RGA) is GRANTED. Ordered by Judge Richard G. Andrews on 6/16/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
June 15, 2023 Filing 157 [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 6/16/2023 (nms).
June 12, 2023 Opinion or Order Filing 156 ORAL ORDER: Defendant USV Private Limited's answer was due to be filed on 6/8/2023 (see D.I. 153 in MDL 21-3017; D.I. 18 in C.A. 22-1492), and to date none has been filed. A status letter is now due no later than three (3) days from the entry of this Order. Ordered by Judge Richard G. Andrews on 6/12/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
June 2, 2023 Opinion or Order Filing 155 STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms).
June 2, 2023 Opinion or Order Filing 154 STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms).
June 1, 2023 Opinion or Order SO ORDERED, re #153 Unopposed Motion to Extend Time (*Reset Answer Deadlines: USV Private Limited answer due 6/8/2023). Signed by Judge Richard G. Andrews on 6/1/2023. (nms)
May 31, 2023 Filing 153 Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/1/2023 (nms).
May 3, 2023 Opinion or Order Filing 152 SO ORDERED Granting (D.I. 151 in 21-md-3017-RGA; D.I. 11 in 23-cv-335-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 5/3/2023. Associated Cases: 1:23-cv-00335-RGA, 1:21-md-03017-RGA(nms)
May 3, 2023 Filing 151 STIPULATION of Dismissal, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/3/2023 (nms).
April 27, 2023 Filing 150 Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/27/2023 (nms).
April 27, 2023 Opinion or Order SO ORDERED, re #150 Unopposed Motion to Extend Time to file answer or otherwise respond to June 1, 2023. Signed by Judge Richard G. Andrews on 4/27/2023. (nms)
April 12, 2023 Filing 149 NOTICE of Appearance by Patricia Smink Rogowski on behalf of ScieGen Pharmaceuticals, Inc. (Rogowski, Patricia)
March 24, 2023 Filing 148 UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until to May 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 3/24/2023 (nms).
March 24, 2023 Opinion or Order SO ORDERED, re (D.I. 148 in 21-md-3017-RGA; D.I. 16 in 22-cv-1492-RGA) Unopposed Motion to Extend Time to Answer or otherwise respond to the Complaint to May 1, 2023. Signed by Judge Richard G. Andrews on 3/24/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
March 17, 2023 Filing 147 NOTICE of Withdrawal of Appearance of Delaware Counsel, Eve Ormerod by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve)
March 8, 2023 Filing 146 NOTICE OF SERVICE of (1) Apotex's ANDA Production and (2) Apotex's Core Technical Documents Production filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth)
March 7, 2023 Filing 145 MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
March 7, 2023 Filing 144 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
March 7, 2023 Filing 143 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
March 7, 2023 Filing 142 Answer to Complaint, Separate Defenses and Counterclaims, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 3/7/2023 (nms).
March 7, 2023 Opinion or Order SO ORDERED, re (D.I. 14 in 22-cv-1596-RGA; D.I. 145 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 3/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms)
February 28, 2023 Filing 141 UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/28/2023 (nms).
February 28, 2023 Opinion or Order SO ORDERED, re ( D.I. 15 in 22-cv-1492-RGA; D.I. 141 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023. Signed by Judge Richard G. Andrews on 2/28/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
February 1, 2023 Filing 140 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Viatris Inc. for Mylan Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
January 31, 2023 Filing 139 Unopposed Motion for Extension of Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/31/2023 (nms).
January 31, 2023 Opinion or Order SO ORDERED, re (D.I. 139 in 21-md-3017-RGA; D.I. 14 in 22-cv-1492-RGA) Unopposed Motion for Extension of Time to answer or otherwise respond to the Complaint until 2/28/2023. Signed by Judge Richard G. Andrews on 1/31/2023. Associated Cases: 1:22-cv-01492-RGA, 1:21-md-03017-RGA(nms)
January 18, 2023 Opinion or Order Filing 138 ORAL ORDER: For the reasons stated on the record on January 18, 2023, a stay of the case is GRANTED until fourteen days after the PTAB issues a final written decision on the related IPR. At that time, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. The motion to extend schedule (D.I. 125) is DISMISSED as moot. Ordered by Judge Richard G. Andrews on 1/18/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
January 18, 2023 Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing on the Motion to Extend Schedule held on 1/18/2023. Counsel for Plaintiffs: D. Fahnestock. Counsel for Defendants: N. Hoeschen, M. Haney, N. Belgam, R. Vrana, D. Moore. No later than 14 days after the PTAB decision, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. (Court Reporter Heather Triozzi.) Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(lah)
January 6, 2023 Opinion or Order Filing 137 ORAL ORDER: A hearing on the Motion to Extend Schedule (D.I. 134 in 21-cv-314-RGA-JLH; D.I. 113 in 21-cv-1742-RGA; D.I. 125 in 21-md-3017-RGA) is now set for 1/18/2023, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/6/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
January 5, 2023 Opinion or Order SO ORDERED, Granting (D.I. 12 in 22-cv-1492-RGA; D.I. 136 in 21-md-3017-RGA) Unopposed Motion to Extend Time to answer or otherwise respond to Complaint to January 31, 2023. Signed by Judge Richard G. Andrews on 1/5/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
January 4, 2023 Filing 136 UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/5/2023 (nms).
January 3, 2023 Filing 135 Letter to The Honorable Richard G. Andrews, from Emily S. DiBenedetto, regarding request for oral argument. (DiBenedetto, Emily) Modified on 1/4/2023 (nms).
December 27, 2022 Filing 134 REPLY Brief in further support to #125 MOTION to Extend Case Schedule, filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit A)(Hoeschen, Nathan) Modified on 12/28/2022 (nms).
December 16, 2022 Filing 133 ANSWERING BRIEF in Opposition re #125 MOTION to Extend Schedule, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/27/2022. (Fahnestock, Derek) Modified on 12/16/2022 (nms).
December 14, 2022 Filing 132 NOTICE of Appearance by James S. Green, Jr on behalf of USV Private Limited (Green, James)
December 14, 2022 Filing 131 NOTICE of Withdrawal of Motion to Extend Schedule (D.I. #125 ), by Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s. (Ormerod, Eve) Modified on 12/14/2022 (nms). Modified on 12/15/2022 (nms).
December 13, 2022 Filing 130 STIPULATION and Proposed Order to Extend Time to file their response to Defendants' Motion to Extend Schedule - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/13/2022 (nms).
December 13, 2022 Filing 129 STIPULATION and [Proposed] Order to Extend Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
December 13, 2022 Opinion or Order SO ORDERED, re (D.I. 137 in 21-cv-314-RGA-JLH; D.I. 116 in 21-cv-1742-RGA, D.I. 129 in 21-md-03017-RGA) Stipulation and Proposed Order to Extend Schedule. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
December 13, 2022 Opinion or Order SO ORDERED, re (D.I. 130 in 21-md-3017-RGA; D.I. 138 in 21-cv-314-RGA-JLH; D.I. 117 in 21-cv-01742-RGA) STIPULATION and Proposed order to Extend Time to file response to Defendants' Motion to Extend Schedule to December 16, 2022. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
December 5, 2022 Filing 128 UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/5/2022 (nms).
December 5, 2022 Opinion or Order SO ORDERED, re (D.I. 10 in 22-cv-1492-RGA; D.I. 128 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer the complaint to 1/5/2023. Signed by Judge Richard G. Andrews on 12/5/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms)
December 2, 2022 Filing 127 NOTICE OF SERVICE of (1) Plaintiff Bayer's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) and (2) Plaintiff Janssen's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
December 1, 2022 Filing 126 MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu)
December 1, 2022 Opinion or Order SO ORDERED, re (D.I. 126 in 21-md-3017-RGA; D.I. 114 in 21-cv-1742-RGA; D.I. 135 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/1/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
November 29, 2022 Set Answering Brief Deadline re #125 MOTION to Extend Schedule. Answering Brief/Response due date per Local Rules is 12/13/2022. (nms)
November 29, 2022 Filing 125 MOTION to Extend Schedule - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 11/29/2022 (nms).
November 29, 2022 CORRECTING ENTRY: The motion to extend schedule filed on 11/28/2022, has been removed from the docket. The filer requested this as an amended motion will be refiled. Associated Cases: 1:21-cv-01742-RGA, 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
November 16, 2022 Opinion or Order Filing 124 SO ORDERED Granting (D.I. 123 in 21-md-3017-RGA; D.I.132 in 21-cv-314-RGA-JLH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/16/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
November 16, 2022 Opinion or Order Filing 123 STIPULATION and Order regarding Infringement by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
November 14, 2022 Filing 122 NOTICE requesting Clerk to remove David M. Knapp as co-counsel.. (Vrana, Robert)
November 14, 2022 Filing 121 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (35 in MDL No. 3017, 2 in NJ/2:22-cv-05485) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 11/14/2022. (Attachments: #1 Transferee Letter) (smg)
November 11, 2022 Filing 120 NOTICE of Change of Firm Affiliation by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert)
November 7, 2022 Filing 119 STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Mylan Pharmaceutical Inc. and Mylan Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
November 2, 2022 Filing 118 NOTICE to Take Deposition of Janssen Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
November 2, 2022 Filing 117 NOTICE to Take Deposition of Bayer Pharma AG and Bayer AG filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
November 2, 2022 Filing 116 NOTICE to Take Deposition of Frank Misselwitz filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
November 2, 2022 Filing 115 NOTICE to Take Deposition of Nancy Cook Bruns filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
October 20, 2022 Filing 114 NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
October 19, 2022 Opinion or Order Filing 113 SO ORDERED Granting (D.I. 123 in 21-cv-314-RGA-JLH; D.I. 112 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/19/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
October 18, 2022 Opinion or Order Filing 112 STIPULATION and Order Regarding Infringement (as to Defendants Lupin Limited and Lupin Pharmaceutical, Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
October 18, 2022 Filing 111 NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s Identification References & Combinations filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Belgam, Neal)
October 18, 2022 Opinion or Order Filing 110 SO ORDERED Granting (D.I. 107 in 21-md-3017-RGA; D.I. 39 in 22-cv-1228-RGA; D.I. 104 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order Consolidating Cases and Adopting Schedule. Signed by Judge Richard G. Andrews on 10/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA, 1:22-cv-01228-RGA(nms)
October 18, 2022 Filing 109 NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
October 17, 2022 Filing 108 NOTICE OF SERVICE of Defendants' Prior Art Narrowing Disclosure (also filed on behalf of Defendant Teva Pharmaceuticals USA, Inc.) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
October 17, 2022 Filing 107 Joint Stipulation and [Proposed] Order Consolidating Cases and Adopting Schedule, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/18/2022 (nms).
October 17, 2022 Filing 106 NOTICE of Withdrawal of Defendants' Motion to Dismiss by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/17/2022 (nms).
October 12, 2022 Filing 105 REDACTED VERSION of #99 Answering Brief in Opposition, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Fahnestock, Derek) Modified on 10/12/2022 (nms).
October 12, 2022 Opinion or Order Filing 104 SO ORDERED Granting (D.I. 117 in 21-cv-314-RGA-JLH; D.I. 102 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
October 11, 2022 Opinion or Order Filing 103 SO ORDERED Granting (D.I. 116 in 21-cv-314-RGA-JLH; D.I. 101 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/11/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
October 11, 2022 Filing 102 STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
October 7, 2022 Opinion or Order Filing 101 STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/11/2022 (nms).
October 3, 2022 Filing 100 ANSWER to Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Fahnestock, Derek) Modified on 10/3/2022 (nms).
October 3, 2022 Filing 99 [SEALED] ANSWERING BRIEF in Opposition re Motion to Dismiss (D.I. 25 in C.A. 22-1228-RGA), filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 10/11/2022. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Fahnestock, Derek) Modified on 10/3/2022 (nms).
September 30, 2022 Filing 98 Joint Stipulation and [Proposed] Order to Extend Time, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 9/30/2022 (nms).
September 30, 2022 Opinion or Order SO ORDERED, re (D.I. 98 in 21-md-3017-RGA; D.I. 115 in 21-cv-314-RGA-JLH; D.I. 103 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 9/30/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
September 23, 2022 Filing 97 STIPULATION TO EXTEND TIME (1) for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to respond to Defendants' Motion to Dismiss (D.I. 25); and (2) for Defendants to file their reply brief to October 3, 2022, and October 17, 2022, respectively - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek)
September 23, 2022 Opinion or Order SO ORDERED, re (D.I. 97 in 21-md-3017-RGA; D.I. 34 in 22-cv-1228-RGA) STIPULATION and Proposed Order to Extend Time to respond to Motion to Dismiss and to file reply brief to October 3, 2022, and October 17, 2022. Signed by Judge Richard G. Andrews on 9/23/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01228-RGA(nms)
September 21, 2022 Filing 96 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. (29 in MDL No. 3017, 1 in WVN/1:22-cv-00063) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/21/2022. (Attachments: #1 Transferee Letter) (smg)
September 19, 2022 Filing 95 NOTICE to Take Deposition of Wayne Talton on October 14, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 94 NOTICE to Take Deposition of Kristen McElwayne on October 13, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 93 NOTICE to Take Deposition of Beth Britton on October 6, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 92 NOTICE to Take Deposition of Natalie Yantovskiy on October 19, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 91 NOTICE to Take Deposition of Miriam Getsis on October 12, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 90 NOTICE to Take Deposition of Avi Avramoff on October 5, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 89 NOTICE to Take Deposition of Makrand Avichat on October 18, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 88 NOTICE to Take Deposition of Pramod Dahibhate on October 11, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 87 NOTICE to Take Deposition of Jason Gensburger on October 4, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 86 NOTICE to Take Deposition of Srinivasa Rao on October 17, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 85 NOTICE to Take Deposition of Sowjanya Madala on October 10, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 19, 2022 Filing 84 NOTICE to Take Deposition of Shobha Chagam on October 3, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 12, 2022 Filing 83 NOTICE OF SERVICE of (1) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.; (2) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.; (3) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.; and (4) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendant Teva Pharmaceuticals USA, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 12, 2022 Filing 82 NOTICE OF SERVICE of Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek)
September 9, 2022 Filing 81 MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek)
September 9, 2022 Filing 80 NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s First Supplemental Objections and Responses to Plaintiffs Bayer Pharma AG and Janssen Pharmaceuticals, Inc.s First Joint Set of Interrogatories filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve)
September 9, 2022 Opinion or Order SO ORDERED, re (D.I. 81 in 21-md-3017-RGA; D.I. 98 in 21-cv-1742-RGA; D.I. 104 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers, filed by Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 9/9/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
September 8, 2022 Filing 79 STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek)
September 8, 2022 Filing 78 MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve)
September 8, 2022 Opinion or Order SO ORDERED, re (D.I. 78 in 21-md-3017-RGA; D.I. 101 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
September 8, 2022 Opinion or Order SO ORDERED, re (D.I. 102 in 21-cv-314-RGA-JLH; D.I. 97 in 21-cv-1742-RGA; D.I. 79 in 21-md-3017-RGA) STIPULATION to Extend Time to substantially complete document production to September 23, 2022. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
September 7, 2022 Filing 77 NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 7, 2022 Filing 76 NOTICE to Take Deposition of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 7, 2022 Filing 75 NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 7, 2022 Filing 74 NOTICE to Take Deposition of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
September 7, 2022 Filing 73 NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. and Mylan Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek)
August 30, 2022 Filing 72 NOTICE of Change of Address by Megan C. Haney (Haney, Megan)
August 24, 2022 Opinion or Order Filing 71 SO ORDERED, re (D.I. 94 in 21-cv-1742-RGA; D.I. 70 in 21-md-3017-RGA; 94 in 21-cv-314-RGA-JLH) STIPULATION to Extend Time for Plaintiffs and Defendants to substantially complete document production to September 9, 2022. Signed by Judge Richard G. Andrews on 8/24/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
August 24, 2022 Filing 70 STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 9, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
August 5, 2022 Filing 69 NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) and (2) Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
July 27, 2022 Opinion or Order SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
July 26, 2022 Filing 68 Joint STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production shall be extended from August 5, 2022 to allow the parties additional time to search for and produce documents to August 26, 2022 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve)
July 12, 2022 Opinion or Order Filing 67 SO ORDERED Granting (D.I. 66 in 21-md-3017-RGA; D.I. 90 in 21-cv-314-RGA-JLH) Stipulation of Dismissal (*Micro Labs USA, Inc. and Micro Labs Limited terminated). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
July 6, 2022 Filing 66 STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/7/2022 (nms).
July 6, 2022 Filing 65 NOTICE OF SERVICE of Lupin's First Set of Requests for Production to Plaintiffs (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
July 1, 2022 Filing 64 STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Hitch, Cortlan) Modified on 7/1/2022 (nms).
July 1, 2022 Opinion or Order SO ORDERED, re (D.I. 88 in 21-cv-314-RGA-JLH; D.I. 64 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order (between Plaintiffs and Defendants "Micro"). Signed by Judge Richard G. Andrews on 7/1/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
June 27, 2022 Opinion or Order Filing 63 SO ORDERED Granting (D.I. 62 in 21-md-3017-RGA: D.I. 86 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/27/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
June 24, 2022 Filing 62 STIPULATION Amend Scheduling Order as to Plaintiffs and Micro Labs by Micro Labs Ltd.. (Hitch, Cortlan)
June 10, 2022 Filing 61 MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve)
June 10, 2022 Opinion or Order SO ORDERED, re (D.I. 61 in 21-md-3017-RGA; D.I. 85 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 6/10/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
June 9, 2022 Filing 60 NOTICE of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve)
June 8, 2022 Filing 59 NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s 1) Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) and 2) Responses and Objections to Plaintiffs' First Joint Set of Interrogatories (Nos. 1-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve)
June 7, 2022 Filing 58 NOTICE OF SERVICE of 1) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Joint Set of Interrogatories; and 2) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Set of Requests for Production filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
June 7, 2022 Filing 57 NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Joint Set Of Interrogatories (Nos. 1-7), and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Set Of Requests For Production (Nos. 1-43) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
June 7, 2022 Filing 56 NOTICE OF SERVICE of 1. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories 2. Teva's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1 - 43) filed by Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
June 6, 2022 Filing 55 NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and Lupin's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
June 2, 2022 Opinion or Order Filing 54 SO ORDERED, re (D.I. 77 in 21-cv-314-RGA-JLH; D.I. 53 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/2/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
June 2, 2022 Filing 53 STIPULATION to Amended Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
June 1, 2022 Filing 52 NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
June 1, 2022 Pro Hac Vice Attorney Frank D. Rodriguez for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
May 31, 2022 Filing 51 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve)
May 31, 2022 Opinion or Order SO ORDERED, re (D.I. 51 in 21-md-3017-RGA; D.I. 75 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 5/31/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 25, 2022 Pro Hac Vice Attorney David M. Knapp for Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
May 25, 2022 Opinion or Order SO ORDERED, re (D.I. 74 in 21-cv-314-RGA-JLH; D.I. 50 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 5/25/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 24, 2022 Filing 50 MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert)
May 24, 2022 Opinion or Order Filing 49 SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 24, 2022 Filing 48 STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms).
May 24, 2022 Opinion or Order SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 23, 2022 Filing 47 STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan)
May 23, 2022 Filing 46 STIPULATION to Amend the Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
May 23, 2022 Opinion or Order SO ORDERED, re (D.I. 46 in 21-md-3017-RGA; D.I. 70 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/23/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 20, 2022 Opinion or Order SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 19, 2022 Filing 45 STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
May 18, 2022 Opinion or Order Filing 44 SO ORDERED Granting (D.I. 84 in 21-cv-1742-RGA; D.I. 42 in 21-md-3017-RGA) Stipulation Amending Order. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
May 18, 2022 Opinion or Order SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
May 17, 2022 Filing 43 STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms).
May 17, 2022 Filing 42 STIPULATION Amending Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms).
May 13, 2022 Filing 41 STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
May 13, 2022 Filing 40 STIPULATION TO EXTEND TIME various dates to dates listed in stipulation - filed by Micro Labs Ltd., Micro Labs USA Inc., Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth)
May 13, 2022 Opinion or Order SO ORDERED, re (D.I. 66 in 21-cv-314-RGA-JLH; D.I. 40 in 21-md-3017-RGA) STIPULATION to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms)
May 13, 2022 Opinion or Order SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms)
May 2, 2022 Filing 39 NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Constructions filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
May 2, 2022 Filing 38 NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek)
April 29, 2022 Opinion or Order SO ORDERED, re #36 Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/29/2022. (nms)
April 29, 2022 Filing 37 NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
April 29, 2022 Filing 36 STIPULATION to Amended Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) Modified on 4/29/2022 (nms).
April 22, 2022 Filing 35 NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
April 18, 2022 Filing 34 NOTICE OF SERVICE of Defendants' First Set Of Joint Interrogatories To Plaintiffs (Nos. 1-9); and Defendants' First Set Of Joint Requests For Production To Plaintiffs (Nos. 1-60) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
April 18, 2022 Filing 33 STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs) by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth)
April 18, 2022 Opinion or Order SO ORDERED, re (D.I. 59 in 21-cv-314-RGA-JLH; D.I. 33 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms)
April 15, 2022 Filing 32 NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
April 5, 2022 Filing 31 NOTICE OF SERVICE of (1) Micro Labs' Rule 26(a)(1) Initial Disclosures; and (2) Micro Labs' Paragraph 3 Disclosures filed by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth)
April 1, 2022 Filing 30 NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures, (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures, and (3) Bayer Pharma AG, Bayer AG's, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
March 28, 2022 Filing 29 Answer to Counterclaims of Defendants Micro Labs Ltd. and Micro Labs USA, Inc. (see C.A. 22-165-RGA, D.I. 10), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/28/2022 (nms).
March 22, 2022 Opinion or Order Filing 28 SCHEDULING ORDER: Civil Action No. 22-165-RGA is consolidated for all purposes, including trial, with Civil Action 21-314-RGA, and all papers shall be filed in Civil Action No. 21-314-RGA. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 7/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A 2 day Bench Trial is set to start 5/30/2023, at 8:30 AM in Courtroom 6A. Signed by Judge Richard G. Andrews on 3/22/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-00165-RGA(nms)
March 21, 2022 Filing 27 PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: #1 Letter)(Fahnestock, Derek) Modified on 3/21/2022 (nms).
March 8, 2022 Filing 26 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Micro Labs Ltd. for Micro Labs USA, Inc. filed by Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth)
March 8, 2022 Filing 25 ANSWER to Complaint and COUNTERCLAIM against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) Modified on 3/9/2022 (nms).
March 2, 2022 Filing 24 NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu)
March 2, 2022 Filing 23 NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Moore, David)
March 1, 2022 Filing 22 NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions with Ex. A filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu)
January 31, 2022 Filing 21 NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu)
January 31, 2022 Opinion or Order Filing 20 ORDER ADOPTING SCHEDULE: The 314 Scheduling Order shall govern in this Action as if entered in this action, except that paragraphs 14-16 pertaining to the pretrial and trial shall not be applicable. Signed by Judge Richard G. Andrews on 1/31/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms)
January 31, 2022 Filing 19 PROPOSED Order Adopting Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Attachments: #1 Letter)(Fahnestock, Derek) Modified on 1/31/2022 (nms).
January 28, 2022 Filing 18 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Teva's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
January 28, 2022 Filing 17 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Taro's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
January 28, 2022 Filing 16 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Mylan's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
January 28, 2022 Filing 15 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Lupin's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
January 28, 2022 Filing 14 NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for DRL's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
January 25, 2022 Opinion or Order Filing 13 ORAL ORDER: The parties are requested to jointly submit a proposed order formally adopting the schedule already in place for related consolidated civil action 21-314-RGA. The proposed order is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/25/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms)
January 18, 2022 Filing 12 Joint Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 1/18/2022 (nms).
January 12, 2022 Opinion or Order Filing 11 ORAL ORDER: A joint status letter is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms)
December 29, 2021 Filing 10 NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Disclosures Pursuant To Paragraph 3 Of The Delaware Default Standard Of Discovery; and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Production Of Core Technical Documents Pursuant To Paragraph 4(b) Of Delawares Default Standard For Discovery [CONFIDENTIAL] filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Moore, David)
December 29, 2021 Filing 9 NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
December 29, 2021 Filing 8 NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek)
December 29, 2021 Filing 7 NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Default Standard Paragraph 3 and 4(b) Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve)
December 29, 2021 Filing 6 NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John)
December 29, 2021 Pro Hac Vice Attorneys Wendy L. Devine, Elham F. Steiner, and Ty W. Callahan for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
December 28, 2021 Filing 5 MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David)
December 28, 2021 Opinion or Order SO ORDERED, re (D.I. 5 in 21-md-3017-RGA,; D.I. 69 in 21-cv-1742-RGA) MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/28/2021. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms)
December 27, 2021 Filing 4 NOTICE OF SERVICE of 1) Initial Disclosures of Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc. Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc.'s core technical documents filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert)
December 17, 2021 Filing 3 ANSWER to Answer to Complaint and Counterclaim, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/20/2021 (nms).
December 16, 2021 Filing 2 NOTICE of Dismissal Without Prejudice of Taro's Counterclaims as to U.S. Patent 9,415,053 by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert)
December 15, 2021 Filing 1 CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg)
December 15, 2021 NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg)
December 15, 2021 Remark: The following cases in the District of Delaware are included in this MDL: 21-cv-314, 21-cv-732, 21-cv-1000, 21-cv-1001, 21-cv-1742. (nmg)
December 15, 2021 NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Clerk of MDL Panel
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Lupin Limited
Represented By: John C. Phillips, Jr.
Represented By: Deepro R. Mukerjee
Represented By: Jillian M. Schurr
Represented By: Jitty Malik, Ph.D.
Represented By: Lance A. Soderstrom
Represented By: Megan C. Haney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Lupin Pharmaceuticals, Inc.
Represented By: John C. Phillips, Jr.
Represented By: Deepro R. Mukerjee
Represented By: Jillian M. Schurr
Represented By: Jitty Malik, Ph.D.
Represented By: Lance A. Soderstrom
Represented By: Megan C. Haney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories, Inc.
Represented By: Neal C. Belgam
Represented By: Anandita Vyakarnam
Represented By: Eve H. Ormerod
Represented By: Frank D. Rodriguez
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories, Ltd.
Represented By: Neal C. Belgam
Represented By: Anandita Vyakarnam
Represented By: Eve H. Ormerod
Represented By: Frank D. Rodriguez
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Taro Pharmaceutical Industries, Ltd.
Represented By: Anne Shea Gaza
Represented By: Kimberly A. Beis
Represented By: David M. Knapp
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Taro Pharmaceuticals U.S.A., Inc.
Represented By: Anne Shea Gaza
Represented By: Kimberly A. Beis
Represented By: David M. Knapp
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Teva Pharmaceuticals USA, Inc.
Represented By: Nathan Roger Hoeschen
Represented By: Brady P. Gleason
Represented By: Chandrika Vira
Represented By: J.C. Rozendaal
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Mylan Pharmaceuticals Inc.
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Represented By: Elham F. Steiner
Represented By: Ty W. Callahan
Represented By: Wendy L. Devine
Represented By: Gordon H. Copland
Represented By: William J O'Brien
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Mylan Inc.
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Represented By: Elham F. Steiner
Represented By: Ty W. Callahan
Represented By: Wendy L. Devine
Represented By: Gordon H. Copland
Represented By: William J O'Brien
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Micro Labs Limited
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Micro Labs USA, Inc.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Bayer Intellectual Property GMBH
Represented By: Derek James Fahnestock
Represented By: Keith J. Miller
Represented By: Rodger Dallery Smith, II
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: USV Private Limited
Represented By: James S. Green, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Apotex Inc.
Represented By: Cortlan S. Hitch
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Apotex Corp.
Represented By: Cortlan S. Hitch
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Macleods Pharmaceuticals Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Macleods Pharma USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Teva Pharmaceutical Industries Ltd
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Indoco Remedies Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: FPP Holding Company LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Biocon Pharma Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Biocon Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Bayer Pharma AG
Represented By: Jack B. Blumenfeld
Represented By: Bruce R. Genderson
Represented By: Derek James Fahnestock
Represented By: Dov P. Grossman
Represented By: Rodger Dallery Smith, II
Represented By: Alexander S. Zolan
Represented By: Kathryn S. Kayali
Represented By: Keith J. Miller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Bayer AG
Represented By: Jack B. Blumenfeld
Represented By: Bruce R. Genderson
Represented By: Derek James Fahnestock
Represented By: Dov P. Grossman
Represented By: Rodger Dallery Smith, II
Represented By: Alexander S. Zolan
Represented By: Kathryn S. Kayali
Represented By: Keith J. Miller
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Janssen Pharmaceuticals, Inc.
Represented By: Jack B. Blumenfeld
Represented By: Derek James Fahnestock
Represented By: Rodger Dallery Smith, II
Represented By: Andrew T. Langford
Represented By: Keith J. Miller
Represented By: Thomas D. Rein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: ScieGen Pharmaceuticals, Inc.
Represented By: Patricia Smink Rogowski
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?